Abénex
Also known as Abenex, ABENEX CAPITAL, Abenex Capital
Paris private equity manager, independent from ABN AMRO since 2008; minority or majority stakes of €10–100m in French and European SMEs and mid-caps; B Corp; €2.5bn raised.
- HEADQUARTERS
- Paris, France
- FOUNDED
- —
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 12 people
FOCUS
- STAGES
- GrowthBuyout
- SECTORS
- HealthTechIndustrial & ManufacturingSoftware & SaaSEducationConsumer & E-commerceClimate & EnergyReal Estate & PropTech
- ASSET MIX
- Private equityReal estateImpact
- GEOGRAPHY
- FranceItalyBelgiumNetherlandsLuxembourgEurope
WHAT IT IS
Private Equity Fund. A fund manager investing limited-partner capital into mature private companies.
- Percier Real EstateAbénex's real-estate activity (value-add operations mainly in Paris, started 2014) being spun off as an independent management company, subject to AMF approval; Abénex remains reference shareholder
ABOUT
Abénex is a Paris-based private equity firm that became independent from ABN AMRO in 2008, with offices in Paris, Lyon, Amsterdam and Milan and more than 45 staff. It invests €10–100m as minority or majority shareholder in SMEs and mid-sized companies through Mid Cap, Small Cap and Industries 9.0 (industrial decarbonisation) strategies, around three themes: improving quality of life, protecting people and assets, and increasing knowledge and optimising resources. It reports €2.5bn of capital raised and more than 100 companies backed, is B Corp certified (2022, recertified 2025) and became an entreprise à mission in 2023; its real-estate activity is being spun off as Percier Real Estate.
INVESTMENT THESIS
Backs SMEs and mid-caps alongside management on three impact themes (quality of life and healthcare, protection of people, assets and data, resource optimisation and education), with a dedicated operating team; Industries 9.0 targets industrial SMEs valued up to €60m with €5–20m tickets and SBTi-aligned decarbonisation plans.
PORTFOLIO (12)
- TethysIndustrial & Manufacturing · since 2026
- HTDSIndustrial & Manufacturing · since 2021
- De Hooge WaerderHealthTech
- ZatoIndustrial & Manufacturing · since 2025
- Groupe EmeraudeFintech · since 2025
- Asgard groupIndustrial & Manufacturing
- SantisHealthTech
- Origin GroupIndustrial & Manufacturing
- Di MarcoIndustrial & Manufacturing
- Propriétés PrivéesReal Estate & PropTech
- Groupe Skin ArtistsHealthTech
- Groupe Leader InsuranceFintech · Exited (2025)
TEAM
- Olivier MoattiAssocié Gérant · source
- Patrice VerrierAssocié Gérant · source
- Johann DupontAssocié et Directeur Général · source
- Hervé ClaquinAssocié Fondateur · source
- Christian DorléacAssocié (Small Cap) · source
- Julien KeignartAssocié (Small Cap) · source
- Emmanuel HerbinetAssocié, head of Abenex Industries 9.0 · source
- Nicolas GoiranAssocié (Industries 9.0) · source
- Mathieu MauhouratAssocié (Mid Cap) · source
- Sander de LangeAssocié, Co-Head Benelux · source
- Coen BarendsenAssocié, Co-Head Benelux · source
- Laurent ChevreauCFO · source
LINKS
FAQ
Abénex is a private equity fund based in Paris, France.
Yes. Abénex invests directly in private companies.
Abénex invests at Growth and Buyout stages in HealthTech, Industrial & Manufacturing, Software & SaaS, Education, Consumer & E-commerce, Climate & Energy and Real Estate & PropTech.
Abénex's stated ticket size is €10M–€100M.
Key people at Abénex include Olivier Moatti (Associé Gérant), Patrice Verrier (Associé Gérant), Johann Dupont (Associé et Directeur Général) and Hervé Claquin (Associé Fondateur).
Abénex's investments include Tethys, HTDS, De Hooge Waerder, Zato, Groupe Emeraude, Asgard group, Santis and Origin Group, among others.
The most recent publicly reported investment by Abénex is Tethys (Buyout (majority stake, fourth investment of Abenex Small Cap II; Bpifrance reinvesting)), announced in May 2026.
Yes. Abénex manages capital from outside investors.